Cognex Corp header image

Cognex Corp

CGNX

Equity

ISIN US1924221039 / Valor 919421

NASDAQ (2025-03-14)
USD 31.51+4.13%

Cognex Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Cognex Corp is a global leader in providing vision systems, software, sensors, and industrial barcode readers for manufacturing automation. With over 40 years of experience and a track record of selling over a million systems, the company has established itself as a key player in the industry. Their innovative technology helps companies improve efficiency, quality control, and productivity in their manufacturing processes.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (24.12.2024):

Revenue Growth

Cognex Corp reported a revenue of $211 million for the first quarter of 2024, marking a 5% increase compared to the same quarter in 2023. This growth was primarily driven by improvements in the Logistics and Semiconductor sectors, despite a decline in the factory automation business. Sequentially, revenue rose by 7% from the fourth quarter of 2023.

Operating Income

For Q1 2024, Cognex Corp's operating income was $14 million, which represents a 36% decrease from the $22 million reported in Q1 2023. However, there was a 12% increase from the previous quarter, Q4 2023. The operating income as a percentage of revenue stood at 6.7% for the quarter.

Net Income and Earnings Per Share

Cognex Corp's net income for the first quarter of 2024 was $12 million, a significant decline of 53% from the $25.6 million reported in Q1 2023. The net income per diluted share was $0.07, consistent with the previous quarter but down from $0.15 in the same quarter last year.

Cash Position and Shareholder Returns

As of March 31, 2024, Cognex Corp maintained a strong financial position with $557 million in cash and investments and no debt. During the quarter, the company generated $14 million in cash from operations, repurchased $9 million worth of its common stock, and paid $13 million in dividends to shareholders.

Financial Outlook for Q2 2024

Looking ahead to the second quarter of 2024, Cognex Corp expects revenue to range between $230 million and $245 million, reflecting a sequential increase due to typical seasonality in consumer electronics. The company anticipates an adjusted gross margin slightly above 70% and plans to continue investing in its Emerging Customer initiative.

Summarized from source with an LLMView Source

Key figures

-22.5%1Y
-51.2%3Y
-29.4%5Y

Performance

38.6%1Y
39.0%3Y
41.9%5Y

Volatility

Market cap

6181 M

Market cap (USD)

Daily traded volume (Shares)

3,943,235

Daily traded volume (Shares)

1 day high/low

36 / 35.08

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Super Micro Computer Inc
Super Micro Computer Inc Super Micro Computer Inc Valor: 138624448
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.91%USD 42.17
LEGRAND SA
LEGRAND SA LEGRAND SA Valor: 2501522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.13%EUR 105.60
Worldline SA
Worldline SA Worldline SA Valor: 24715654
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.17%EUR 6.97
Rexel SA
Rexel SA Rexel SA Valor: 3015581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.65%EUR 25.17
Ascendis Pharma
Ascendis Pharma Ascendis Pharma Valor: 26912602
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.44%USD 152.98
OVH GROUPE
OVH GROUPE OVH GROUPE Valor: 114137816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%EUR 7.98
Vetoquinol SA
Vetoquinol SA Vetoquinol SA Valor: 1393361
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%EUR 71.60
Neurones
Neurones Neurones Valor: 837153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.29%EUR 49.15
SOLUTIONS 30 SE
SOLUTIONS 30 SE SOLUTIONS 30 SE Valor: 44600804
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.68%EUR 1.69
Novanta Inc
Novanta Inc Novanta Inc Valor: 32582414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.19%USD 136.07